Tag Archives: rosiglitazone
Senate report links Avandia to increased risk of heart attacks, death. What am I telling my Avandia patients to do?
In a front-page story, the New York Times reported, “Hundreds of people taking Avandia [rosiglitazone], a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports.” A Senate Finance Committee review cites internal FDA … Continue reading
Reuters is reporting the American Diabetes Association featuring dueling studies on the question of whether intensive blood sugar lowering in diabetics provides health benefits. (see also the coverage on WebMD)